Interview: Paul Rees on leaving the NPA to ‘clamp down on racism’ at nursing regulator

Interview Paul Rees On Leaving The NPA To ‘clamp Down On Racism’ At Nursing Regulator

After 14 months with the National Pharmacy Association (NPA), Paul Rees told The Pharmacist why he couldn’t turn down the opportunity to make a difference at the NMC, one of the biggest organisations in healthcare.

On 20 January 2025, Mr Rees will begin his new role as interim chief executive of the Nursing and Midwifery Council (NMC).

He’ll be tasked with transforming a ‘dangerously toxic’ and ‘dysfunctional’ culture at one of the biggest healthcare regulators in the world.

‘This role is all about improving the NMC’s wider organisational culture, including embedding equality, diversity and inclusion: clamping down, if you like, on racism or discrimination within the NMC – to ensure that the NMC does a better job of protecting the public, running fair processes, and ensuring that the staff team are treated with respect,’ Mr Rees told The Pharmacist in an interview before Christmas.

Related Article: Anticoagulant Inhixa recalled due to typo

Last year, an independent review team issued a damning report which found that bullying, racism and burnout within the NMC was putting nurses and the public at risk.

Serious concerns were also raised about the regulators fitness to practice (FTP) proceedings, including ‘some really worrying examples of safeguarding failures’, according to the independent report.

Mr Rees told The Pharmacist that he accepted the role at the NMC because he had ‘always cared passionately about equality, diversity and inclusion, and also [about] culture being right.’

At the NPA, Mr Rees and the board have written a new strategy for the organisation that embeds ‘equality, diversity and inclusion as a priority’.

The association also celebrated International Women’s Day, Pride, Black History Month, and South Asian Heritage Month for the first time in 2024.

And Mr Rees spoke out to support the sector as violent, racist and Islamophobic unrest swept the country in August.

Related Article: Interview: Pharmacy First saves time, prevents escalation, and frees up capacity

‘I think I was the first leader in pharmacy to say where patients were abusive, racist or Islamophobic, pharmacy teams should refuse to serve them and turn them away,’ he told The Pharmacist.

While Mr Rees said he had ‘loved working with the NPA’, the role at the NMC appealed to him ‘because it meant that one of the things I was really passionate about, I would be able to help drive through’.

‘‘I’m also going to have a laser focus on the delivery of the NMC’s core regulatory work, and obviously [if] the NMC manages to embed equality, diversity, inclusion, it really will help ensure that all nurses and midwives and nursing associates, whatever their background, whatever the characteristics, will be confident that there will be an effective and fair process run by the NMC,’ he said.

‘It is a big job,’ he added.

With 1,300 staff and 830,000 registrants, the NMC ‘is one of the biggest health regulators in the world’, Mr Rees said.

Related Article: New GPhC chief standards officer appointed

‘In healthcare, there aren't many jobs that are bigger,’ he added.

‘It's really exciting to be in a position, if you like, of privilege that you can try to ensure an inclusive, high performing culture, because that impacts on so many people.’

'Toxic’ and ‘dysfunctional’: What did the independent review into the nursing regulator find?

An independent review of the UK’s nursing regulator in 2024 identified a ‘dangerously toxic culture’ in which bullying, racism and burnout are putting nurses and the public at risk.

The damning report called for an ‘urgent turnaround plan’ to ‘stop a dysfunctional culture’ at the NMC.

Led by former public prosecutor Nazir Afzal, with Rise Associates, the review warned of an NMC workforce that is ‘really struggling’ and an environment where ‘poor judgement, toxic behaviours and paralysis is affecting decision-making’.

Related Article: Anticoagulant Inhixa recalled due to typo

And it revealed serious concerns around the way in which fitness to practise (FtP) cases are handled, including that action was being taken ‘against good nurses’ while ‘bad nurses get away with it’.

At the time, the NMC issued an apology and promised action to ‘deliver a culture change programme’ following a series of recommendations in the report, including more investment in people, a faster screening process to tackle complaints, a new safeguarding hub and increased black and ethnic minority managers so they can better understand the communities they serve.

Rise Associates and Mr Afzal were commissioned to complete the independent cultural review of the NMC in January 2024, following a series of disclosures by a whistleblower in 2023, who accused the NMC of a ‘deep seated toxic culture’.

Former NMC chief executive and registrar Andrea Sutcliffe stepped down from her role just before the report's publication due to ill-health.

She said at the time: ‘Having received the draft of this important report three weeks after my decision to step down, I know there is powerful testimony from colleagues sharing their stories about racism, discrimination and bullying and their views of the NMC. It’s extremely important for the organisation to truly listen and respond.'

Related Article: Interview: Pharmacy First saves time, prevents escalation, and frees up capacity

Ms Sutcliffe was replaced on an interim basis by Dawn Brodrick in July 2024, who then resigned four days after her appointment was announced following concerns raised around her reported links to a high-profile discrimination case while working at an NHS trust.

NMC executive director of resources and technology services Helen Herniman then started in an acting capacity some days later.

In October 2024, the NMC appointed equality, diversity and inclusion (EDI) advisor Mac Alonge to its executive board and council.

Related Article: New GPhC chief standards officer appointed

And in November 2024, it was announced that Paul Rees would take on the post for a period of 12 months from 20 January 2025.

The above reporting on the 2024 independent review into the NMC was first published by Madeleine Anderson at our sister title Nursing in Practice.

Want news like this straight to your inbox?
Sign up for our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.